Table 2.
Quintile of 25-Hydroxyvitamin D Concentrationa |
Doubling of Concentration |
P for Trendb | P for Heterogeneityc | ||||||||||
1d | 2 |
3 |
4 |
5 |
|||||||||
OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI | ||||
Range, nmol/L | 2.5−40.4 | 40.5−50.4 | 50.5−59.1 | 59.2−70.8 | 70.9−163.7 | ||||||||
No. of cases | 125 | 143 | 128 | 114 | 142 | ||||||||
No. of controls | 151 | 150 | 151 | 150 | 150 | ||||||||
Odds ratioe | 1 | 1.24 | 0.88, 1.74 | 1.15 | 0.82, 1.62 | 1.01 | 0.71, 1.45 | 1.24 | 0.87, 1.79 | 1.13 | 0.91, 1.41 | 0.265 | |
Adjusted odds ratiof | 1 | 1.27 | 0.89, 1.81 | 1.23 | 0.85, 1.76 | 1.06 | 0.73, 1.55 | 1.28 | 0.88, 1.88 | 1.17 | 0.93, 1.47 | 0.188 | |
Prostate cancer stagef | |||||||||||||
Localized (n = 326) | 1 | 1.28 | 0.76, 2.16 | 1.20 | 0.72, 1.97 | 1.09 | 0.65, 1.83 | 1.15 | 0.67, 1.97 | 1.12 | 0.80, 1.56 | 0.508 | 0.577 |
Advanced (n = 122) | 1 | 1.61 | 0.71, 3.65 | 1.10 | 0.40, 2.99 | 0.83 | 0.32, 2.12 | 1.13 | 0.37, 3.43 | 1.31 | 0.73, 2.37 | 0.364 | |
Histologic gradef | |||||||||||||
Low (n = 362) | 1 | 1.45 | 0.89, 2.37 | 1.37 | 0.85, 2.21 | 1.30 | 0.79, 2.15 | 1.52 | 0.91, 2.56 | 1.29 | 0.95, 1.74 | 0.097 | 0.108 |
High (n = 170) | 1 | 0.94 | 0.42, 2.10 | 0.63 | 0.26, 1.49 | 0.86 | 0.36, 2.05 | 0.83 | 0.34, 2.07 | 0.94 | 0.52, 1.70 | 0.846 | |
Age at blood collectionf | |||||||||||||
<60 years (n = 112) | 1 | 2.02 | 0.59, 6.90 | 1.87 | 0.65, 5.37 | 3.73 | 1.06, 13.17 | 2.90 | 0.85, 9.88 | 1.90 | 0.99, 3.64 | 0.046 | 0.160 |
≥60 years (n = 540) | 1 | 1.30 | 0.89, 1.90 | 1.19 | 0.79, 1.77 | 0.93 | 0.62, 1.40 | 1.19 | 0.78, 1.80 | 1.07 | 0.83, 1.39 | 0.594 |
Abbreviations: CI, confidence interval; OR, odds ratio.
Serum concentrations of vitamin D were standardized for month of blood collection.
Values were obtained with the logarithm of plasma 25-hydroxyvitamin D replacing the categorical plasma 25-hydroxyvitamin D variable in the model.
Values relate to likelihood ratio chi-squared tests of heterogeneity between trends for localized and advanced-stage and low- and high-grade prostate cancer, and for age <60 years and ≥60 years at blood collection.
All values of 1 are odds ratios.
Conditioned on matching variables by using conditional logistic regression.
Conditioned on matching variables and adjusted for body mass index, smoking, alcohol intake, education, marital status, and physical activity by using conditional logistic regression.